A detailed history of Israel Englander (Millennium Management LLC) transactions in Genfit S.A. stock. As of the latest transaction made, Millennium Management LLC holds 29,717 shares of GNFT stock, worth $117,976. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,717
Previous 28,310 4.97%
Holding current value
$117,976
Previous $108,000 2.78%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$3.34 - $4.04 $4,699 - $5,684
1,407 Added 4.97%
29,717 $105,000
Q4 2023

Feb 14, 2024

BUY
$2.97 - $3.94 $84,080 - $111,541
28,310 New
28,310 $108,000
Q1 2023

May 15, 2023

SELL
$3.93 - $4.69 $2,849 - $3,400
-725 Reduced 1.24%
57,781 $233,000
Q4 2022

Feb 14, 2023

BUY
$3.53 - $4.39 $2,728 - $3,393
773 Added 1.34%
58,506 $255,000
Q3 2022

Nov 14, 2022

SELL
$3.26 - $4.86 $1.17 Million - $1.75 Million
-359,828 Reduced 86.17%
57,733 $211,000
Q2 2022

Aug 15, 2022

SELL
$3.09 - $4.25 $7,029 - $9,668
-2,275 Reduced 0.54%
417,561 $1.35 Million
Q1 2022

May 16, 2022

BUY
$3.14 - $5.04 $85,781 - $137,687
27,319 Added 6.96%
419,836 $1.68 Million
Q4 2021

Feb 14, 2022

BUY
$3.01 - $5.65 $222,944 - $418,484
74,068 Added 23.26%
392,517 $1.96 Million
Q3 2021

Nov 15, 2021

SELL
$3.58 - $4.14 $75,452 - $87,254
-21,076 Reduced 6.21%
318,449 $1.18 Million
Q2 2021

Aug 16, 2021

BUY
$3.8 - $4.63 $94,798 - $115,504
24,947 Added 7.93%
339,525 $1.31 Million
Q1 2021

May 17, 2021

BUY
$4.53 - $6.06 $1.14 Million - $1.52 Million
251,626 Added 399.71%
314,578 $1.45 Million
Q4 2020

Feb 16, 2021

BUY
$3.63 - $5.6 $228,515 - $352,531
62,952 New
62,952 $302,000
Q2 2020

Aug 14, 2020

SELL
$5.2 - $22.0 $1.55 Million - $6.56 Million
-298,331 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$10.95 - $20.76 $2.55 Million - $4.83 Million
232,640 Added 354.14%
298,331 $4.3 Million
Q4 2019

Feb 14, 2020

SELL
$13.55 - $20.14 $844,300 - $1.25 Million
-62,310 Reduced 48.68%
65,691 $1.31 Million
Q3 2019

Nov 14, 2019

SELL
$14.92 - $19.94 $109,557 - $146,419
-7,343 Reduced 5.43%
128,001 $2.23 Million
Q2 2019

Aug 15, 2019

BUY
$19.74 - $25.65 $1 Million - $1.3 Million
50,807 Added 60.1%
135,344 $2.67 Million
Q2 2019

Aug 14, 2019

SELL
$19.74 - $25.65 $1.36 Million - $1.77 Million
-68,891 Reduced 44.9%
84,537 $5.05 Million
Q1 2019

May 14, 2019

BUY
$22.17 - $24.0 $3.4 Million - $3.68 Million
153,428 New
153,428 $3.68 Million

Others Institutions Holding GNFT

About Genfit S.A.


  • Ticker GNFT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,815,500
  • Market Cap $198M
  • Description
  • Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...
More about GNFT
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.